Amdocs Historical Income Statement

DOX Stock  USD 89.90  0.52  0.58%   
Historical analysis of Amdocs income statement accounts such as Total Revenue of 3.1 B or Gross Profit of 1.1 B can show how well Amdocs performed in making a profits. Evaluating Amdocs income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Amdocs's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Amdocs latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amdocs is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

About Amdocs Income Statement Analysis

Amdocs Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Amdocs shareholders. The income statement also shows Amdocs investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Amdocs Income Statement Chart

Amdocs Income Statement is one of the three primary financial statements used for reporting Amdocs's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Amdocs revenue and expense. Amdocs Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Amdocs' Interest Expense is fairly stable compared to the past year. Interest Income is likely to rise to about 25.7 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 181.9 M in 2024.

Total Revenue

Total revenue comprises all receipts Amdocs generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Amdocs minus its cost of goods sold. It is profit before Amdocs operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Amdocs. It is also known as Amdocs overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Amdocs operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Amdocs is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most accounts from Amdocs' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Interest Expense is fairly stable compared to the past year. Interest Income is likely to rise to about 25.7 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 181.9 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.7B2.0B1.1B
Total Revenue4.6B4.9B5.6B3.1B

Amdocs income statement Correlations

0.450.910.910.920.80.790.860.870.910.940.840.10.840.810.920.36-0.110.470.18-0.35-0.39-0.20.2
0.450.540.540.530.430.440.610.460.530.50.610.20.590.710.480.8-0.470.820.56-0.93-0.94-0.470.46
0.910.541.01.00.920.920.990.961.00.990.920.060.920.860.990.49-0.060.540.3-0.47-0.5-0.260.32
0.910.541.01.00.920.930.990.961.00.990.910.040.910.850.990.49-0.080.530.33-0.48-0.5-0.270.34
0.920.531.01.00.910.920.980.961.01.00.910.060.920.860.990.48-0.050.530.29-0.45-0.49-0.250.31
0.80.430.920.920.910.960.910.960.910.910.77-0.230.780.670.920.33-0.060.330.33-0.35-0.46-0.230.32
0.790.440.920.930.920.960.920.990.920.910.71-0.320.710.630.920.28-0.10.30.4-0.37-0.48-0.30.38
0.860.610.990.990.980.910.920.940.980.980.910.050.910.850.980.55-0.090.570.37-0.56-0.58-0.280.37
0.870.460.960.960.960.960.990.940.950.960.77-0.230.770.70.960.31-0.10.360.36-0.38-0.48-0.280.35
0.910.531.01.01.00.910.920.980.950.990.920.070.920.860.990.49-0.050.540.29-0.46-0.5-0.260.31
0.940.50.990.991.00.910.910.980.960.990.890.030.90.831.00.44-0.080.50.31-0.44-0.46-0.250.32
0.840.610.920.910.910.770.710.910.770.920.890.421.00.960.890.7-0.020.720.17-0.54-0.51-0.20.23
0.10.20.060.040.06-0.23-0.320.05-0.230.070.030.420.410.460.010.530.250.54-0.38-0.19-0.030.22-0.26
0.840.590.920.910.920.780.710.910.770.920.91.00.410.940.890.680.00.690.16-0.52-0.49-0.180.21
0.810.710.860.850.860.670.630.850.70.860.830.960.460.940.810.79-0.110.850.23-0.65-0.6-0.280.27
0.920.480.990.990.990.920.920.980.960.991.00.890.010.890.810.42-0.080.470.32-0.43-0.43-0.250.33
0.360.80.490.490.480.330.280.550.310.490.440.70.530.680.790.42-0.340.960.43-0.84-0.72-0.460.47
-0.11-0.47-0.06-0.08-0.05-0.06-0.1-0.09-0.1-0.05-0.08-0.020.250.0-0.11-0.08-0.34-0.34-0.80.530.390.87-0.8
0.470.820.540.530.530.330.30.570.360.540.50.720.540.690.850.470.96-0.340.39-0.84-0.72-0.450.42
0.180.560.30.330.290.330.40.370.360.290.310.17-0.380.160.230.320.43-0.80.39-0.71-0.55-0.860.8
-0.35-0.93-0.47-0.48-0.45-0.35-0.37-0.56-0.38-0.46-0.44-0.54-0.19-0.52-0.65-0.43-0.840.53-0.84-0.710.880.56-0.54
-0.39-0.94-0.5-0.5-0.49-0.46-0.48-0.58-0.48-0.5-0.46-0.51-0.03-0.49-0.6-0.43-0.720.39-0.72-0.550.880.44-0.41
-0.2-0.47-0.26-0.27-0.25-0.23-0.3-0.28-0.28-0.26-0.25-0.20.22-0.18-0.28-0.25-0.460.87-0.45-0.860.560.44-0.81
0.20.460.320.340.310.320.380.370.350.310.320.23-0.260.210.270.330.47-0.80.420.8-0.54-0.41-0.81
Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization198.4M208.8M224.5M195.7M225.1M181.9M
Interest Expense10.4M21.3M26.4M17.6M20.3M21.3M
Total Revenue4.2B4.3B4.6B4.9B5.6B3.1B
Gross Profit1.4B1.5B1.6B1.7B2.0B1.1B
Other Operating Expenses3.6B3.7B3.9B4.2B4.8B2.7B
Operating Income594.8M372.3M664.8M654.0M752.1M403.8M
Ebit594.8M372.3M664.8M724.9M833.6M431.2M
Research Development282.0M312.9M354.7M374.9M431.1M221.8M
Ebitda793.2M581.1M889.3M920.6M1.1B613.1M
Cost Of Revenue2.8B2.8B3.0B3.2B3.6B2.0B
Total Operating Expenses818.7M879.0M954.4M1.0B1.2B684.0M
Income Before Tax583.3M814.3M648.4M636.4M731.8M423.0M
Total Other Income Expense Net(11.4M)442.0M(16.4M)(70.9M)(81.5M)(77.5M)
Net Income497.8M688.4M549.5M540.7M621.8M350.4M
Income Tax Expense85.5M125.9M98.9M93.4M107.4M72.5M
Selling General Administrative458.5M487.3M528.6M570.7M656.3M390.6M
Net Income Applicable To Common Shares479.4M497.8M688.4M549.5M631.9M396.4M
Net Income From Continuing Ops497.8M688.4M549.5M543.0M624.4M531.0M
Tax Provision85.5M125.9M98.9M93.4M107.4M95.1M
Interest Income4.2M4.8M7.8M21.2M24.4M25.7M
Net Interest Income(11.4M)(10.8M)(26.4M)(17.6M)(15.9M)(15.1M)
Reconciled Depreciation198.4M208.8M224.5M195.7M176.1M166.8M

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Moving against Amdocs Stock

  0.75AVPTW AvePointPairCorr
  0.66EGIO Edgio Inc Tech BoostPairCorr
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.18
Dividend Share
1.74
Earnings Share
4.68
Revenue Per Share
41.665
Quarterly Revenue Growth
0.05
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.